This is a synthetic peptide designed for use in combination with anti-ATXN2 antibody (Catalog #: ARP38210_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
The autosomal dominant cerebellar ataxias (ADCA) are a heterogeneous group of neurodegenerative disorders characterized by progressive degeneration of the cerebellum, brain stem and spinal cord. Clinically, ADCA has been divided into three groups: ADCA ty
Alias Symbols: ATX2, FLJ46772, SCA2, TNRC13
Protein Interaction Partner: A2BP1,ACTN1,ACTN2,ATXN1,BAT3,BIN1,CHGB,GFI1B,IDH3B,KIAA1279,LCP1,NCOA4,PABPC1,PLS3,SH3GL2,SH3GL3,TDRD7,ZNRD1,CD247,CHGB,VHL